Highest Analyst Upside Stocks
INSP is part of our highest analyst upside stock list, indicating analysts have a price target way above the current price.
INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Price & Overview
NYSE:INSP • US4577301090
Current stock price
56.31 USD
-0.04 (-0.07%)
At close:
56.31 USD
0 (0%)
After Hours:
The current stock price of INSP is 56.31 USD. Today INSP is down by -0.07%. In the past month the price increased by 11.62%. In the past year, price decreased by -64.6%.
INSP Key Statistics
52-Week Range48.3 - 163.35
Current INSP stock price positioned within its 52-week range.
1-Month Range48.3 - 58.98
Current INSP stock price positioned within its 1-month range.
- Market Cap
- 1.622B
- P/E
- 22.43
- Fwd P/E
- 28.24
- EPS (TTM)
- 2.51
- Dividend Yield
- N/A
INSP Stock Performance
Today
-0.07%
1 Week
-2.22%
1 Month
+11.62%
3 Months
-29.08%
Longer-term
6 Months -27.36%
1 Year -64.60%
2 Years -76.70%
3 Years -78.96%
5 Years -76.22%
10 Years N/A
INSP Stock Chart
INSP Stock Screens
INSP currently appears in the following ChartMill screener lists.
INSP Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to INSP. When comparing the yearly performance of all stocks, INSP is a bad performer in the overall market: 94.4% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
INSP Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to INSP. INSP has an excellent financial health rating, but there are some minor concerns on its profitability.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
INSP Earnings
On February 11, 2026 INSP reported an EPS of 1.62 and a revenue of 269.08M. The company beat EPS expectations (81.33% surprise) and missed revenue expectations (-0.7% surprise).
Next Earnings DateMay 4, 2026
Last Earnings DateFeb 11, 2026
PeriodQ4 / 2025
EPS Reported$1.62
Revenue Reported269.077M
EPS Surprise 81.33%
Revenue Surprise -0.70%
INSP Forecast & Estimates
25 analysts have analysed INSP and the average price target is 91.79 USD. This implies a price increase of 63% is expected in the next year compared to the current price of 56.31.
For the next year, analysts expect an EPS growth of -20.55% and a revenue growth 6.34% for INSP
Analysts
Analysts72
Price Target91.79 (63.01%)
EPS Next Y-20.55%
Revenue Next Year6.34%
INSP Groups
Sector & Classification
Sector
Health Care Sub-Industry
Health Care Equipment INSP Financial Highlights
Over the last trailing twelve months INSP reported a non-GAAP Earnings per Share(EPS) of 2.51. The EPS increased by 45.09% compared to the year before.
Income Statements
Revenue(TTM)911.98M
Net Income(TTM)145.42M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 15.95% | ||
| ROA | 16.03% | ||
| ROE | 18.62% | ||
| Debt/Equity | 0 |
Chartmill High Growth Momentum
EPS Q2Q%40.87%
Sales Q2Q%12.25%
EPS 1Y (TTM)45.09%
Revenue 1Y (TTM)13.6%
INSP Ownership
Ownership
Inst Owners120.05%
Shares28.80M
Float28.43M
Ins Owners1.01%
Short Float %11.26%
Short Ratio2.58
INSP Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 41.34 | 170.062B | ||
| ABT | ABBOTT LABORATORIES | 14.5 | 160.7B | ||
| SYK | STRYKER CORP | 21.66 | 126.249B | ||
| BSX | BOSTON SCIENTIFIC CORP | 15.72 | 97.627B | ||
| EW | EDWARDS LIFESCIENCES CORP | 24.95 | 45.962B | ||
| IDXX | IDEXX LABORATORIES INC | 38.22 | 44.549B | ||
| BDX | BECTON DICKINSON AND CO | 11.15 | 44.092B | ||
| RMD | RESMED INC | 17.91 | 31.978B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.32 | 31.89B | ||
| DXCM | DEXCOM INC | 24.21 | 24.131B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.76 | 17.894B | ||
| PODD | INSULET CORP | 29.24 | 13.313B | ||
| PEN | PENUMBRA INC | 64.72 | 13.094B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About INSP
Company Profile
Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The company is headquartered in Golden Valley, Minnesota and currently employs 1,333 full-time employees. The company went IPO on 2018-05-03. The firm is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The firm sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Company Info
IPO: 2018-05-03
INSPIRE MEDICAL SYSTEMS INC
5500 Wayzata Blvd Ste 1600
Golden Valley MINNESOTA 55416 US
CEO: TimothyP. Herbert
Employees: 1333
Phone: 17639575037
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
What does INSPIRE MEDICAL SYSTEMS INC do?
Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The company is headquartered in Golden Valley, Minnesota and currently employs 1,333 full-time employees. The company went IPO on 2018-05-03. The firm is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The firm sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Can you provide the latest stock price for INSPIRE MEDICAL SYSTEMS INC?
The current stock price of INSP is 56.31 USD. The price decreased by -0.07% in the last trading session.
Does INSP stock pay dividends?
INSP does not pay a dividend.
What is the ChartMill rating of INSPIRE MEDICAL SYSTEMS INC stock?
INSP has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
On which exchange is INSP stock listed?
INSP stock is listed on the New York Stock Exchange exchange.
What is the next earnings date for INSP stock?
INSPIRE MEDICAL SYSTEMS INC (INSP) will report earnings on 2026-05-04, after the market close.
What is the Short Interest ratio of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The outstanding short interest for INSPIRE MEDICAL SYSTEMS INC (INSP) is 11.26% of its float.